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FLUORESCENT TREPONEMAL ANTIBODY STUDIES*
W. E. DEACON, PH.D. AND ELIZABETH M. FREEMAN, MS.
Fluorescent antibody methods were originally
introduced by Coons and associates in 1942. In-
cluded in this first publication was a procedure
for antibody-fluorescein conjugation and a de-
scription of fluorescent reactions obtaincd by
means of ultraviolet light microscopy. This com-
munication, and later ones by other authors, indi-
cated that fluorescent antibody procedures were
practical for rapid and direct identification of
infectious agents, and might be applied in a
variety of fields.
Fluorescent antibody reactions may be ob-
tained in either of two ways. The direct reaction
is most frequently employed for pathogen iden-
tification and consists of preparing a highly
specific antiserum in an appropriate animal and
conjugating the gamma globulin with fluorescein.
The value of the finished product or conjugate is
judged by its ability to react with, or stain, a
specific pathogen and no others.
The indirect reaction in contrast to the direct
procedure is performed in two stages. First, the
pathogen is treated with a specific unlabeled anti-
serum (example: rabbit serum); and then after
washing thoroughly to remove unreaeted serum,
fluoreseein labeled goat antirabbit globulin is ap-
plied to detect the presence of rabbit antibody.
The Fluorescent Treponemal Antibody (FTA)
test is an example of the indirect reaction, and as
employed, is used to detect human treponemal
antibody. Since the pathogen (Treponema palli-
dum) is a known quantity, the procedure has
been modified to detect the unknown quantity
(human treponemal antibody or human globulin).
The FTA test is performed in the following
manner. First, Treponema pallidum is extracted
from rabbits in the same manner as is used in the
Treponema Pallidum Immobilization (TPI) test.
The intact treponemes are dried on microscope
slides, and after fixing with acetone, are exposed
to the human test serums. Slides are gently ro-
tated at 37° C. to facilitate antibody coupling,
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and are then thoroughly washed with saline to
remove excess serum. Fluorescein labeled anti-
human globulin, the reaction indicator, is then
added to the smear. Treponemes which have
coupled with human antibody will, in turn,
couple with the fluoreseein conjugate. The reac-
tion can then be visualized with an ultraviolet
light microscope. A smear treated with a strongly
reactive serum will reveal brilliantly fluorescent
treponemes. A smear treated with a serum con-
taining smaller amounts of antibody will demon-
strate treponemes with less brilliance or none
at all.
FTA reactions are illustrated in the following
photomierographs:
Figure 1—Treponema palliduin as seen by
the usual darkfield using tungsten light.
Figure 2—Treponema pallidum, weakly
fluorescent as seen by UV light (weakly reactive
serum—treponemes with less brilliance would
not be seen) and would constitute a nonreactive
result.
Figure 3—Treponeina pallidum, brilliantly
fluorescent as seen with UV light—reactive result.
On the basis of extended studies, the antibodies
detected by the FTA test appear to be similar or
identical to those identified by the well known
TPI test. This conclusion is supported by com-
parative findings in the Serology Evaluation and
Research Assembly (SERA) Study conducted in
1957 by the Venereal Disease Branch, CDC. In
this work, six TPI procedures, as performed by
five laboratories, are compared. The following re-
sults illustrate the close agreement of TPI and
FTA findings.
In Category A, Presumed Normals—346
specimens
Range TPI's 1.7—5.5% Reactive
PTA 1 .5% Reactive
Category B, Diseases Other Than Syphilis—
83 specimens
Range TPI's 9—13% Reactive
FTA 7% Reactive
Category C, Untreated Primary Syphilis—130
specimens
Range TPI's 25—50% Reactive
PTA 60% Reactive
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Category D, Treated Early Syphilis—51
specimens
Range TPI's 27—53% Reactive
FTA 38% Reactive
Category H, Lcprosy—29 specimens
Range TPI's 0—3% Reactive
FTA 0% Reactive
The following slides illustrate the relative
sensitivity and specificity of various test pro-
cedures entered in the SERA Study. Sensitivity
as used in these illustrations is based on known
syphilis categories consisting of 504 specimens
(early, untreated; early, treated; and late,
treated). Specificity is based on results obtained
with Presumed Normals, and Diseases Other
Than Syphilis, consisting of 409 specimens.
Figure 4 shows the distribution of test re-
sults. Circles indicate Treponema pallidum tests,
triangles are lipoidal tests, squares arc Reiter
treponeme procedures. The large square at the
FIG, 2
Vu;. I
FLUORESCENT TREPONEMAL ANTIBODY 251
FIG. 3
SEROLOGY EVALUATION AND RESEARCH
SPECIFICITY. PERCENT
rz;i
£
left encloses those tests with the most desirable
results in terms of specificity and sensitivity.
Figure 5 is an enlargement of the left hand
square. Test results are identified. Three Trep-
onema pallidtm tests (TPI, U. Michigan, TPI-
200, VDRL), FTA (VDRL), are within the
square. Of the three procedures, the FTA test in
this analysis is the most favorably located.
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Further studies on the mechanism of the FTA
test have now been accomplished and may be
described briefly as follows:
Lipid antibody produced in rabbits by injec-
tion of VDRL antigen, when used in the FTA
procedure, reveals that surface antigens of
Treponema pallidum do not react with this ma-
terial. On the other hand, contaminating sub-
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stances which are found to be present in all
treponemal smears obtained from rabbit testes
were shown to react with lipid antibody. This
finding suggested that normal testicular tissue
might serve as a source of nonspecific reactivity.
The removal of reactivity to VDRL antigen from
rabbit and human sera by absorption with normal
testicular tissue has proven this antigenie
relationship.
Absorption of reactive serum with VDRL anti-
gen removes the reactivity with several sero-
logical tests for syphilis, but leaves reactivity
when tested with the FTA procedure and the
TPI.
Since Hardy, et al., and other workers have
described intact Treponema patlidum antigens as
being reactive in both lipid and treponemal anti-
body systems, an investigation of the Hardy anti-
gen in the PTA procedure was undertaken.
Smears were prepared in the usual manner using
Hardy's antigen and were exposed to rabbit anti-
VDRL antigen globulin. Subsequent treatment
with fluoreseein labeled goat antirabbit indicator
confirmed the lipid antigenie activity of Trepo-
nema paltidum prepared by the Hardy method.
On the basis of this experiment and those previ-
ously described, it would appear that reactive
lipids are not a part of the normal antigenic sur-
face constituents of intact Treponema patlidum
as used in the TPI test. The source of this mate-
rial, as previously indicated, is probably normal
testicular antigen which has been placed on the
treponeme surfaces during the extraction process.
CONCLUSIONS
The FTA test is basically a simple procedure.
Problems arising from nonspecifleity are most
likely concerned with the treponemes (lipid anti-
gens), and as a result, carefully tested antigens
should be selected. That is, each new batch of
antigen should be checked for lipid contamina-
tion. This may be done by checking with anti-
lipid serums. Also, tests should be made for sensi-
tization of the treponemes by rabbit antibodies.
Once an antigen has been found satisfactory, it
may be stored in several ways, such as, refrigera-
tion at 50 C., freezing at —4Q° C., and by lyo-
philizing. Fluoreseein labeled antihuman and
antirabbit globulins are available commercially.
The greatest cost appears to be in purchasing
fluorescent equipment. However, with the in-
creasing applications of fluorescent antibody
technies, the need for such expenditure is justified.
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DISCUSSION
Da. MARION B. SULZBERGER (New York,
N. Y.): I would like to just discuss the point
about the absorption of the anti-lipoidal anti-
bodies by the testicular material. I would like to
ask Dr. Freeman and Dr. Deacon whether they
have tried the fluorescent antibody technic against
the culture Reiter treponemes, which might not
carry any of these organ materials since they
have been cultured on thioglycollate medium. If
the authors have done so, what have the results
been?
DR. Dt& L. SCHAMBERG (Elkins Park, Pa.): As
a syphilophile for a good many years now, I am
gratified to hear this group of three papers on
syphilis. They bespeak our continued interest in
syphilology, a field to which our professional for-
bears contributed much of which we are proud.
I am especially proud to recall my own father's
clinical and laboratory studies in syphilis. But
there are signs in recent years that we are losing
onr interest in this fascinating disease. Only one
of the papers presented today was by a member
of our dermatologie fraternity. Fewer and fewer
of us have a major interest in syphilis. Hence, the
death of Dr. Charles Rein a few years ago was
not only a tragedy to those of us who loved him,
but left an unfilled void in the field to which he
gave so much.
We hear the plaint that there are not enough
syphilitic patients in teaching hospitals to train
students. Bruce Webster of New York gave a
most stimulating talk at the recent Symposium
on Venereal Diseases in Baltimore on this sub-
ject. He pointed out that the crying need is for
somebody interested in teaching syphilis. Such a
man will find plenty of material in any hospital
today. In a community hospital in an upper mid-
dle class area of Philadelphia, with which I am
connected, I saw within the past six weeks one
patient with advanced tabes dorsalis, one with a
wide open syphilitic aortic regurgitation, one
with a syphilitic aortic aneurysm filling half of his
chest as well as, of course, a number of serologic
problems.
I am happy to have heard these papers. I hope
we will hear more of them as the years go on. I
hope that dermatologists will continue to be
syphilologists.
MISS ELIZABETH M. FREEMAN (in closing):
Thank you for the discussion. In answer to Dr.
Sulzberger's question, the use of the Reiter
treponeme in the FTA test has not given specific
reactions in our hands. This is probably due to
lipid antigen on its surface. The availability of
fluorescein isothiocyanate, and the brilliance ob-
tained when using this compound, offers the
opportunity to label specific sera to prove the
relationship of the Reiter and the Nichol strain.
We feel these findings may be very interesting.
